3,3-dimethyl-3H-pyrano[3,2-f]quinoline | 139457-37-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 3,3-dimethyl-3H-pyrano[3,2-f]quinoline
• 英文别名: 3,3-dimethylpyrano[3,2-f]quinoline
• CAS: 139457-37-7
• 化学式: C₁₄H₁₃NO
• 分子量: 211.263
• InChiKey: QGFGTUFQKGRXSH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  22.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3,3-dimethyl-3H-pyrano[3,2-f]quinoline 以 甲苯 为溶剂， 生成 5-[3-Methyl-but-2-en-(Z)-ylidene]-5H-quinolin-6-one
  参考文献：
  名称：

  萘并吡喃，吡喃并喹啉，吡喃并喹唑啉和吡喃并喹喔啉的合成及光致变色行为

  摘要：

  用不同的六元氮杂杂环稠新色烯制备，即，在3 ħ -pyra-无[3,2- ˚F〕喹啉9/10和14中，8 ħ吡喃并[2,3- ħ ]异喹啉11， 8 ħ吡喃并[3,2- ˚F ] quinazolme 12，8- ħ吡喃并[3,2- ˚F ]喹喔啉13，和2 ħ吡喃并[2,3- ˚F ]异喹啉15。使用便利取代的α，β-不饱和醛和氮杂环杂环酚产生的有机钛中间体可以完成合成。除了相应的萘并吡喃以外，还研究了它们的光致变色行为（光致变色产率，光merocyanines的UV / VIS光谱，热漂白速率常数）。通过研究光致变色性质和溶剂效应，定量研究了吡喃部分中的杂环效应和取代基的作用。二芳基取代的叠氮基稠合色酮，特别是异喹啉衍生物，对光金属花青显示出更高的着色能力和红移谱，为光致变色应用开辟了新的前景。

  DOI：

  10.1002/hlca.19970800310
• 作为产物：
  描述：

  6-[(1,1-dimethyl-2-propynyl)oxy]quinoline 在 ethyl acetate n-hexane 作用下， 以 邻二氯苯 为溶剂， 反应 1.0h， 以to obtain the aimed compound (2-steps, quant.)的产率得到3,3-dimethyl-3H-pyrano[3,2-f]quinoline
  参考文献：
  名称：

  Tricyclic benzopyran compound as anti-arrhythmic agents

  摘要：

  本发明涉及公式（I）或（II）的苯并吡喃衍生物或其药学上可接受的盐，其中R1和R2独立地为氢原子，C1-6烷基或C6-14芳基，R3为氢原子或C1-6烷基羰氧基，或与R4一起形成键，R4为氢原子，或与R3一起形成键，m为0至4的整数，n为0至4的整数，V为单键，CR7R8，NR9，O，S，SO或SO2，R5为氢原子或C1-6烷基，R6为氢原子，C1-6烷基，C3-8环烷基，C3-8环烯基，氨基，C1-6烷基氨基，二C1-6烷基氨基，C6-14芳基氨基，C2-9杂芳基氨基，C6-14芳基，C2-9杂芳基或C2-9杂环基，A为与苯环融合的5、6或7元环，作为环的组分原子，氧原子，氮原子或硫原子可以单独或组合地包含其中，环中不饱和键的数量为1、2或3，包括苯环的不饱和键，构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常剂。

  公开号：

  US07652008B2

文献信息

• [EN] TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS<br/>[FR] COMPOSE DE BENZOPYRANNE TRICYCLIQUE EN TANT QU'AGENTS ANTI-ARRYTHMIQUES
  申请人：NISSAN CHEMICAL IND LTD

  公开号：WO2005090357A1

  公开（公告）日：2005-09-29

  This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereof wherein R1 and R2 are independently of each other hydrogen atom, C1-6alkyl group or C6-14aryl group, R3 is hydrogen atom or C1-6alkylcarbonyloxy group, or together with R4 forms a bond, R4 is hydrogen atom, or together with R3 forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR7R8, NR9, O, S, SO or SO2, R5 is hydrogen atom or C1-6alkyl group, R6 is hydrogen atom, C1-6alkyl group, C3-8cycloalkyl group, C3-8cycloalkenyl group, amino group, C1-6alkylamino group, di-C1-6alkylamino group, C6-14arylamino group, C2-9heteroarylamino group, C6-14aryl group, C2-9heteroaryl group or C2-9heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.

  本发明涉及公式（I）或（II）的苯并吡喁衍生物，或其药学上可接受的盐，其中R1和R2分别是氢原子、C1-6烷基或C6-14芳基，R3是氢原子或C1-6烷基羰氧基，或与R4一起形成键，R4是氢原子，或与R3一起形成键，m是0到4的整数，n是0到4的整数，V是单键，CR7R8，NR9，O，S，SO或SO2，R5是氢原子或C1-6烷基，R6是氢原子，C1-6烷基，C3-8环烷基，C3-8环烯基，氨基，C1-6烷基氨基，二C1-6烷基氨基，C6-14芳基氨基，C2-9杂芳基氨基，C6-14芳基，C2-9杂芳基或C2-9杂环烷基，A是与苯环融合的5、6或7成员环，作为环的组成原子，氧原子、氮原子或硫原子可以单独或组合地包含在其中，环中的不饱和键数为1、2或3，包括与苯环融合的不饱和键，构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常药物。
• Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents
  申请人：Ohrai Kazuhiko

  公开号：US20080004262A1

  公开（公告）日：2008-01-03

  This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereof wherein R 1 and R 2 are independently of each other hydrogen atom, C 1-6 alkyl group or C 6-14 aryl group, R 3 is hydrogen atom or C 1-6 alkylcarbonyloxy group, or together with R 4 forms a bond, R 4 is hydrogen atom, or together with R 3 forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR 7 R 8 , NR 9 , O, S, SO or SO 2 , R 5 is hydrogen atom or C 1-6 alkyl group, R 6 is hydrogen atom, C 1-6 alkyl group, C 3-8 cycloalkyl group, C 3-8 cycloalkenyl group, amino group, C 1-6 alkylamino group, di-C 1-6 alkylamino group, C 6-14 arylamino group, C 2-9 heteroarylamino group, C 6-14 aryl group, C 2-9 heteroaryl group or C 2-9 heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.

  本发明涉及式（I）或（II）的苯并吡喃衍生物，或其药学上可接受的盐，其中R1和R2独立地为氢原子，C1-6烷基或C6-14芳基；R3为氢原子或C1-6烷基羰氧基，或与R4一起形成键；R4为氢原子，或与R3一起形成键；m为0至4的整数，n为0至4的整数，V为单键，CR7R8，NR9，O，S，SO或SO2；R5为氢原子或C1-6烷基，R6为氢原子，C1-6烷基，C3-8环烷基，C3-8环烯基，氨基，C1-6烷基氨基，二C1-6烷基氨基，C6-14芳基氨基，C2-9杂芳基氨基，C6-14芳基，C2-9杂芳基或C2-9杂环烷基；A为与苯环融合的5、6或7元环，作为环的组成原子，其中单独或组合存在1至3个氧原子、氮原子或硫原子，环中不饱和键的数量为1、2或3，包括与苯环融合的不饱和键，构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常药物。
• Tricyclic benzopyran compound as anti-arrhythmic agents
  申请人：Nissan Chemical Industries, Ltd.

  公开号：US07652008B2

  公开（公告）日：2010-01-26

  This invention relates to benzopyran derivatives of formula (I) or (II), or pharmaceutically acceptable salts thereof wherein R1 and R2 are independently of each other hydrogen atom, C1-6alkyl group or C6-14aryl group, R3 is hydrogen atom or C1-6alkylcarbonyloxy group, or together with R4 forms a bond, R4 is hydrogen atom, or together with R3 forms a bond, m is an integer of 0 to 4, n is an integer of 0 to 4, V is a single bond, CR7R8, NR9, O, S, SO or SO2, R5 is hydrogen atom or C1-6alkyl group, R6 is hydrogen atom, C1-6alkyl group, C3-8cycloalkyl group, C3-8cycloalkenyl group, amino group, C1-6alkylamino group, di-C1-6alkylamino group, C6-14arylamino group, C2-9heteroarylamino group, C6-14aryl group, C2-9heteroaryl group or C2-9heterocyclyl group, A is 5-, 6- or 7-member ring fused with benzene ring, as constituent atom of the ring, oxygen atom, nitrogen atom or sulfur atom may be contained in the number of 1 to 3 alone or in a combination thereof, the number of unsaturated bond in the ring is 1, 2 or 3 including an unsaturated bond of the benzene ring to be fused, carbon atoms constituting the ring may be carbonyl or thiocarbonyl. These compounds are useful as an anti-arrhythmic agent.

  本发明涉及公式（I）或（II）的苯并吡喃衍生物或其药学上可接受的盐，其中R1和R2独立地为氢原子，C1-6烷基或C6-14芳基，R3为氢原子或C1-6烷基羰氧基，或与R4一起形成键，R4为氢原子，或与R3一起形成键，m为0至4的整数，n为0至4的整数，V为单键，CR7R8，NR9，O，S，SO或SO2，R5为氢原子或C1-6烷基，R6为氢原子，C1-6烷基，C3-8环烷基，C3-8环烯基，氨基，C1-6烷基氨基，二C1-6烷基氨基，C6-14芳基氨基，C2-9杂芳基氨基，C6-14芳基，C2-9杂芳基或C2-9杂环基，A为与苯环融合的5、6或7元环，作为环的组分原子，氧原子，氮原子或硫原子可以单独或组合地包含其中，环中不饱和键的数量为1、2或3，包括苯环的不饱和键，构成环的碳原子可以是羰基或硫代羰基。这些化合物可用作抗心律失常剂。
• TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS
  申请人：Nissan Chemical Industries, Ltd.

  公开号：EP1732929B1

  公开（公告）日：2010-10-20
• US7652008B2
  申请人：——

  公开号：US7652008B2

  公开（公告）日：2010-01-26

表征谱图